EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

LC-MS/MS Profiling and In Silico-Predicted Cyclooxygenase-2 (COX-2) Inhibitory Potential of Compounds from Togaku Rheumatic Oil

Erwince Fallo, Patrisius Maryanto Bria, Dimas Andrianto, R. Haryo Bimo Setiarto

Biointerface Research in Applied Chemistry · 15.08.2026 · 16 (4)

DOI: 10.33263/briac164.103 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biointerface Research in Applied Chemistry, online erschienen am 15.08.2026. Verfasst von Erwince Fallo und 3 weiteren Autor:innen. Die Arbeit nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This study investigated the chemical composition of Togaku rheumatic oil and computationally evaluated its cyclooxygenase-2 (COX-2)-related anti-inflammatory potential using an integrated LC–MS/MS, molecular docking, and in silico ADMET approach. LC–MS/MS profiling identified 13 putatively identified compounds, indicating a chemically complex multiherbal formulation. However, compound identification was based on database matching without confirmation using authentic standards, and relative peak areas were interpreted as semi-quantitative estimates rather than absolute concentrations. Among the detected compounds, Solanapyrone G was identified as the predominant annotated constituent. Molecular docking analysis revealed that Solanapyrone G and 6-undecylsalicylic acid exhibited favorable predicted binding interactions with the COX-2 active site, with docking scores (-9.922 kcal/mol) comparable to the reference ligand rofecoxib and higher than those of ibuprofen under the applied computational conditions. Solanapyrone G exhibited predicted interactions with key residues in the COX-2 active site, including ARG120, TYR355, and SER530, suggesting a plausible binding mode within the COX-2 active pocket. In contrast, 6-undecylsalicylic acid appeared to be stabilized predominantly through hydrophobic interactions within the binding pocket, with no distinct hydrogen-bond or electrostatic interactions detected in the 2D interaction analysis. Nevertheless, these computational results do not establish direct inhibitory potency, as no experimental COX-2 inhibition assay was performed in this study. Computational ADMET predictions further suggested that Solanapyrone G possesses a favorable pharmacokinetic and toxicity profile, characterized by good distribution, low predicted toxicity, and minimal risk of drug–drug interactions, although moderate intestinal absorption was predicted. Overall, these findings provide a preliminary chemical and computational basis supporting the traditional anti-inflammatory use of Togaku rheumatic oil while highlighting the need for further compound confirmation and experimental validation through in vitro and in vivo studies to substantiate its biological activity and safety.

Zitieren

APA

Fallo, E., Bria, P. M., Andrianto, D., & Setiarto, R. H. B. (2026). LC-MS/MS Profiling and In Silico-Predicted Cyclooxygenase-2 (COX-2) Inhibitory Potential of Compounds from Togaku Rheumatic Oil. Biointerface Research in Applied Chemistry, 16(4). https://doi.org/10.33263/briac164.103

Vancouver

Fallo E, Bria PM, Andrianto D, Setiarto RHB. LC-MS/MS Profiling and In Silico-Predicted Cyclooxygenase-2 (COX-2) Inhibitory Potential of Compounds from Togaku Rheumatic Oil. Biointerface Research in Applied Chemistry. 2026;16(4). doi:10.33263/briac164.103

BibTeX
@article{Fallo2026,
  author = {Fallo, Erwince and Bria, Patrisius Maryanto and Andrianto, Dimas and Setiarto, R. Haryo Bimo},
  title = {LC-MS/MS Profiling and In Silico-Predicted Cyclooxygenase-2 (COX-2) Inhibitory Potential of Compounds from Togaku Rheumatic Oil},
  journal = {Biointerface Research in Applied Chemistry},
  year = {2026},
  volume = {16},
  number = {4},
  doi = {10.33263/briac164.103}
}
Kostenlos starten →